Low aortic valve gradient and LV dysfunction are commonly seen in patients undergoing TAVR, but only the former is independently associated with poorer outcomes in the first year following the ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- Hemodynamics offers clues on which low-risk patients ...
Please provide your email address to receive an email when new articles are posted on . TAVR may improve kidney function for more patients than it worsens in low-flow, low-gradient aortic stenosis.
CHICAGO, IL—The incidence of valve hemodynamic deterioration is approximately 2% at both 30 days and 18 months among patients undergoing transcatheter aortic valve replacement, but the changes in the ...
PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...
Two years ago, Dr Raj Makkar (Cedars Sinai, Los Angeles, CA) and colleagues stunned the cardiology community with their discovery of subclinical leaflet thrombosis in bioprosthetic aortic valves—both ...